Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
about
Interleukin-35: Expanding Its Job ProfileT Helper Lymphocyte Subsets and Plasticity in Autoimmunity and Cancer: An OverviewRegulatory B10 cell development and functionBeta-Defensin 124 Is Required for Efficient Innate Immune Responses in Prostate Epithelial RWPE-1 Cells.Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.IL-12 family cytokines: immunological playmakersInterleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathwayDifferences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusionInflammatory cytokines in aqueous humor of patients with choroidal neovascularization.Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family.Prevention of autoimmune diabetes by ectopic pancreatic β-cell expression of interleukin-35.The analysis of correlation between IL-12 gene expression and hepatitis B virus in the affected patients.Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.Targeting inflammation in emerging therapies for genetic retinal diseaseCytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection.Human interleukin 23 receptor induces cell apoptosis in mammalian cells by intrinsic mitochondrial pathway associated with the down-regulation of RAS/mitogen-activated protein kinase and signal transducers and activators of transcription factor 3 siMeprin metalloproteases inactivate interleukin 6.Cytokines and the skin barrier.STAT heterodimers in immunity: A mixed message or a unique signal?IL-35: a potential therapeutic target for controlling hepatitis B virus infection.Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling.A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases.Non-canonical interleukin 23 receptor complex assembly: p40 protein recruits interleukin 12 receptor β1 via site II and induces p19/interleukin 23 receptor interaction via site III.Cytokines and Chemokines in Mycobacterium tuberculosis Infection.The Role of Cytokines in the Development of Atherosclerosis.Preclinical validation: LV/IL-12 transduction of patient leukemia cells for immunotherapy of AML.Identification of canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the intracellular domain of the interleukin 23 receptor.Differential expression, modulation and bioactivity of distinct fish IL-12 isoforms: implication towards the evolution of Th1-like immune responses.Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.IL-27 - a double agent in the IL-6 family.
P2860
Q26829619-8A5F0AF5-E3AE-44BF-B689-EAC20F9AFFBAQ28081582-6A3B24E1-D546-4AA2-9086-82BFC79F83EFQ28087437-EEC601A7-9BA3-4DAC-87AB-62B80336A6A9Q30032681-DD38684D-91E8-49B3-876F-3F5645C2C95CQ30244926-677516D6-86DF-4636-BE9B-3CF761425D93Q34153998-8CAEA400-3CE1-4A1B-985B-E5D6A1E7FB2CQ34634806-55CDF4D7-1EF2-4940-A8DE-A70F618A8956Q34826956-FD329DEC-455B-41F6-8E36-C7EF5D424F1DQ35818087-02427BD1-6213-4EB5-9B8C-62946200A916Q35926091-A9CDA2B8-83F6-4604-B250-510EE9ED60B8Q35976659-950F3166-E27A-4521-9A6C-3B695B6F0857Q36064368-4DFE65CA-7370-43D1-97F1-D481A99D0EE6Q36501690-57E51776-3201-49D0-995F-BBACF0D7915EQ36676772-7CD00E7E-2C1D-43CA-85F0-00EFD2C7BA9AQ36990515-93D9EFE2-38C8-4521-AA13-94592808F5EBQ37365279-C4361E66-F7BE-4631-8DCB-48FBD875AF54Q37421049-FC27FCF4-6B31-4702-9FC0-6723EBA3E359Q37635798-EBAC256B-3E76-42CB-9E90-2DCD071EBC8BQ38093338-A1C415C0-CD2B-494F-8170-6B2490842BB9Q38140902-AF93CC24-F5E1-4698-9A19-2430586429B1Q38283391-AB18B3FB-8B4B-4F8F-9042-16D25A4D2297Q38712876-FDE9E325-76DA-41C6-B5DF-6BBF5464B48AQ38749257-8DB58091-7FB7-4C3C-B15F-7BD7D7FCD1C4Q38942632-ACDF183F-251D-403B-BEED-2903CD4122A4Q38986062-46C84B0C-08A2-4EAA-BB9A-350E62EBFCD8Q39028288-407AF95B-D538-4B00-83A6-E208798FE7C9Q41909592-CC1BD430-8203-41F9-BC65-5B71E0872701Q41973739-A5635E06-9326-4FFA-AF2D-5ADB4E842106Q42240646-5960D571-3CB3-495D-8EE4-7C994830361CQ42381249-B4257772-52C9-468B-8688-680EBD001D82Q50045633-D3815CC1-D3BA-4B02-BC73-6289681C89DF
P2860
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
@en
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
@nl
type
label
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
@en
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
@nl
prefLabel
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
@en
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
@nl
P2860
P1433
P1476
Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily.
@en
P2093
Dario A A Vignali
Lindsay L Jones
P2860
P2888
P356
10.1007/S12026-011-8209-Y
P577
2011-10-01T00:00:00Z